Skip to main content

Bell & Brown Wealth Advisors, LLC

SEC CIK
0001725362
Latest filing
Aug 10, 2026

IBRX holding history

ImmunityBio, Inc. in every 13F filed by Bell & Brown Wealth Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

IBRX overviewAll 13F holders of IBRXFull Q2 2026 holdings

Shares (Q2 2026)
75,050
Value
$657.1K
% of portfolio
0.2%
Quarters held
12
Since Q2 2023
Holdings of IBRX by Bell & Brown Wealth Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202675,050$657.1K0.2%00.0%UnchangedHolders
Q1 202675,050$575.6K0.2%−7,600−9.2%ReducedHolders
Q4 202582,650$163.6K0.1%−100−0.1%ReducedHolders
Q3 202582,750$203.6K0.1%+5,000+6.4%AddedHolders
Q2 202577,750$205.3K0.1%+19,050+32.5%AddedHolders
Q1 202558,700$176.7K0.1%+17,300+41.8%AddedHolders
Q4 202441,400$106.0K<0.1%+4,500+12.2%AddedHolders
Q3 202436,900$137.3K0.1%+2,500+7.3%AddedHolders
Q2 202434,400$217.4K0.1%+100+0.3%AddedHolders
Q1 202434,300$184.2K0.1%−100−0.3%ReducedHolders
Q4 202334,400$172.7K0.1%–No prior filingHolders
Q3 2023––––Not filedHolders
Q2 202320,100$55.9K<0.1%+20,100NewHolders